Polyunsaturated phospholipids promote the oxidation and fragmentation of γ-hydroxyalkenals: Formation and reactions of oxidatively truncated ether phospholipids

Journal of Lipid Research

Volumn 49, Issue 4, 2008, Pages 832-846

  Chen, Xi ^a   Zhang, Wujuan ^a   Laird, James ^a   Hazen, Stanley L ^b   Salomon, Robert G ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Liquid chromatography tandem mass spectrometry; Low density lipoprotein; Myeloperoxidase; Platelet activating factor

Indexed keywords

2 LYSOPHOSPHATIDYLCHOLINE; ALDEHYDE DERIVATIVE; CARBOXYLIC ACID; ESTER DERIVATIVE; ETHER PHOSPHOLIPID; GAMMA HYDROXYALKENAL DERIVATIVE; LINOLEIC ACID; MYELOPEROXIDASE; PHOSPHATIDYLCHOLINE; POLYUNSATURATED FATTY ACID; PYRROLE DERIVATIVE; SCAVENGER RECEPTOR; UNCLASSIFIED DRUG; ALKENE; ETHER; PHOSPHOLIPID;

ARTICLE; AUTOOXIDATION; CHEMICAL STRUCTURE; COVALENT BOND; FRAGMENTATION REACTION; LIPID COMPOSITION; MOLECULAR STABILITY; OXIDATION; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; PROTEIN BINDING; STRUCTURE ANALYSIS; CHEMISTRY; HYDROXYLATION; MASS SPECTROMETRY; OXIDATION REDUCTION REACTION; SYNTHESIS;

ALKENES; ETHER, ETHYL; HYDROXYLATION; MASS SPECTROMETRY; MOLECULAR STRUCTURE; OXIDATION-REDUCTION; PHOSPHOLIPIDS;

EID: 44949088826     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M700598-JLR200     Document Type: Article

References (44)

1. Ross, R. 1995. Cell biology of atherosclerosis. Annu. Rev. Physiol. 57: 791-804.
2. Hoff, H. F., C. L. Heideman, J. W. Gaubatz, A. M. Gotto, Jr., E. E. Erickson, and R. L.Jackson. 1977. Quantification of apolipoprotein B in grossly normal human aorta. Circ. Res. 40: 56-64.
3. Steinberg, D., S. Parthasarathy, T. E. Carew, J. C. Khoo, and J. L. Witztum. 1989. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320: 915-924.
4. Witztum, J. L., and D. Steinberg. 1991. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88: 1785-1792.
5. Henriksen, T., E. M. Mahoney, and D. Steinberg. 1981. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. Proc. Natl. Acad. Sci. USA. 78: 6499-6503.
6. Steinberg, D. 1997. Low density lipoprotein oxidation and its pathobiological significance. J. Biol. Chem. 272: 20963-20966.
7. Tokumura, A., M. Toujima, Y. Yoshioka, and K. Fukuzawa. 1996. Lipid peroxidation in low density lipoproteins from human plasma and egg yolk promotes accumulation of1-acyl analogues of platelet-activating factor-like lipids. Lipids. 31: 1251-1258.
8. Heery, J. M., M. Kozak, D. M. Stafforini, D. A. Jones, G. A. Zimmerman, T. M. Mclntyre, and S. M. Prescott. 1995. Oxidatively modified LDL contains phospholipids with platelet-activating factorlike activity and stimulates the growth of smooth muscle cells. J. Clin. Invest. 96: 2322-2330.
9. Marathe, G. K., S. S. Davies, K. A. Harrison, A. R. Silva, R. C. Murphy, H. Castro-Faria-Neto, S. M. Prescott, G. A. Zimmerman, and T. M. Mclntyre. 1999. Inflammatory platelet-activating factor-like phospholipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholines. J. Biol. Chem. 274: 28395-28404.
10. Berliner, J. A., G. Subbanagounder, N. Leitinger, A. D. Watson, and D. Vora. 2001. Evidence for a role of phospholipid oxidation products in atherogenesis. Trends Cardiovasc. Med. 11: 142-147.
11. Watson, A. D., N. Leitinger, M. Navab, K. F. Faull, S. Horkko, J. L. Witztum, W. Palinski, D. Schwenke, R. G. Salomon, W. Sha, et al. 1997. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J. Biol. Chem. 272: 13597-13607.
12. Watson, A. D., M. Navab, S. Y. Hama, A. Sevanian, S. M. Prescott, D. M. Stafforini, T. M. McIntyre, B. N. Du, A. M. Fogelman, and J. A. Berliner. 1995. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. J. Clin. Invest. 95: 774-782.
13. Parhami, F., A. D. Morrow, J. Balucan, N. Leitinger, A. D. Watson, Y. Tintut, J. A. Berliner, and L. L. Demer. 1997. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler. Thromb. Vasc. Biol. 17: 680-687.
14. Subbanagounder, G., Y. Deng, C. Borromeo, A. N. Dooley, J. A. Berliner, and R. G. Salomon. 2002. Hydroxy alkenal phos-pholipids regulate inflammatory functions of endothelial cells. Vascul. Pharmacol. 38: 201-209.
15. Podrez, E. A., M. Febbraio, N. Sheibani, D. Schmitt, R. L. Silverstein, D. P. Hajjar, P. A. Cohen, W. A. Frazier, H. F. Hoff, and S. L. Hazen. 2000. Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. J. Clin. Invest. 105: 1095-1108.
16. Podrez, E. A., E. Poliakov, Z. Shen, R. Zhang, Y. Deng, M. Sun, P. J. Finton, L. Shan, B. Gugiu, P. L. Fox, et al. 2002. Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36. J. Biol. Chem. 277: 38503-38516.
17. Sun, M., S. C. Finnemann, M. Febbraio, L. Shan, S. P. Annangudi, E. A. Podrez, G. Hoppe, R. Darrow, D. T. Organisciak, R. G. Salomon, et al. 2006. Light-induced oxidation of photoreceptor outer segment phospholipids generates ligands for CD36-mediated phagocytosis by retinal pigment epithelium: a potential mechanism for modulating outer segment phagocytosis under oxidant stress conditions. J. Biol. Chem. 281: 4222-4230.
18. Boullier, A., K. L. Gillotte, S. Horkko, S. R. Green, P. Friedman, E. A. Dennis, J. L. Witztum, D. Steinberg, and O. Quehenberger. 2000. The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein. J. Biol. Chem. 275: 9163-9169.
19. Karakatsani, A. I., T. A. Liapikos, A. N. Troganis, and D. C. Tsoukatos. 1998. Involvement of phospholipids in apolipoprotein B modification during low density lipoprotein oxidation. Lipids. 33: 1159-1162.
20. Hoff, H. F., J. O'Neil, Z. Wu, G. Hoppe, and R. L. Salomon. 2003. Phospholipid hydroxyalkenals: biological and chemical properties of specific oxidized lipids present in atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 23: 275-282.
21. Ebrahem, Q., K. Renganathan, J. Sears, A. Vasanji, X. Gu, L. Lu, R. G. Salomon, J. W. Crabb, and B. Anand-Apte. 2006. Carboxy-ethylpyrrole oxidative protein modifications stimulate neovascularization: implications for age-related macular degeneration. Proc. Natl. Acad. Sci. USA. 103: 13480-13484.
22. Prescott, S. M., G. A. Zimmerman, D. M. Stafforini, and T. M. Mclntyre. 2000. Platelet-activating factor and related lipid mediators. Annu. Rev. Biochem. 69: 419-445.
23. Ishii, S., and T. Shimizu. 2000. Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. Prog. Lipid Res. 39: 41-82.
24. Marathe, G. K., K. A. Harrison, R. C. Murphy, S. M. Prescott, G. A. Zimmerman, and T. M. McIntyre. 2000. Bioactive phospholipid oxidation products. Free Radic. Biol. Med. 28: 1762-1770.
25. Davies, S. S., A. V. Pontsler, G. K. Marathe, K A. Harrison, R. C. Murphy, J. C. Hinshaw, G. D. Prestwich, A. S. Hilaire, S. M. Prescott, G. A. Zimmerman, et al. 2001. Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists. J. Biol. Chem. 276: 16015-16023.
26. Gu, X., M. Sun, B. Gugiu, S. Hazen, J. W. Crabb, and R. G. Salomon. 2003. Oxidatively truncated docosahexaenoate phospholipids: total synthesis, generation, and peptide adduction chemistry. J. Org. Chem. 68: 3749-3761.
27. Gugiu, B. G., C. A. Mesaros, M. Sun, X. Gu, J. W. Crabb, and R. G. Salomon. 2006. Identification of oxidatively truncated ethanolamine phospholipids in retina and their generation from polyunsat- urated phosphatidylethanolamines. Chem. Res. Toxicol. 19: 262-271.
28. Podrez, E. A., E. Poliakov, Z. Shen, R. Zhang, Y. Deng, M. Sun, P. J. Finton, L. Shan, M. Febbraio, D. P. Hajjar, et al. 2002. A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions. J. Biol. Chem. 277: 38517-38523.
29. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917.
30. Kates, M. 1986. Techniques of Lipidology: Isolation, Analysis and Identification of Lipids. 2nd revised edition. (Elsevier, Amsterdam).
31. 3H]-trans- 4-hydroxy-2-nonenal. J. Org. Chem. 63: 3504-3507.
32. Sun, M., Y. Deng, E. Batyreva, W. Sha, and R. G. Salomon. 2002. Novel bioactive phospholipids: practical total syntheses of products from the oxidation of arachidonic and linoleic esters of 2-lysophosphatidylcholine(1). J. Org. Chem. 67: 3575-3584.
33. Hazen, S. L., R. Zhang, Z. Shen, W. Wu, E. A. Podrez, J. C. MacPherson, D. Schmitt, S. N. Mitra, C. Mukhopadhyay, Y. Chen, et al. 1999. Formation of nitric oxide-derived oxidants by myeloperoxidase in monocytes: pathways for monocyte-mediated protein nitration and lipid peroxidation in vivo. Circ. Res. 85: 950-958.
34. Noguchi, N., K. Nakano, Y. Aratani, H. Koyama, T. Kodama, and E. Niki. 2000. Role of myeloperoxidase in the neutrophil-induced oxidation of low density lipoprotein as studied by myeloperoxidase- knockout mouse. J. Biochem. (Tokyo). 127: 971-976.
35. van der Vliet, A., J. P. Eiserich, B. Halliwell, and C. E. Cross. 1997. Formation of reactive nitrogen species during peroxidase- catalyzed oxidation of nitrite. A potential additional mechanism of nitric oxide-dependent toxicity. J. Biol. Chem. 272: 7617-7625.
36. Greenberg, M. E., M. Sun, R. Zhang, M. Febbraio, R. Silverstein, and S. L. Hazen. 2006. Oxidized phosphatidylserine-CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells. J. Exp. Med. 203: 2613-2625.
37. Gu, X., S. G. Meer, M. Miyagi, M. E. Rayborn, J. G. Hollyfield, J. W. Crabb, and R. G. Salomon. 2003. Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration. J. Biol. Chem. 278: 42027-42035.
38. Crabb, J. W., M. Miyagi, X. Gu, K. Shadrach, K. A. West, H. Sakaguchi, M. Kamei, A. Hasan, L. Yan, M. E. Rayborn, et al. 2002. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc. Natl. Acad. Sci. USA. 99: 14682-14687.
39. Gao, S., R. Zhang, M. E. Greenberg, M. Sun, X. Chen, B. S. Levison, R. G. Salomon, and S. L. Hazen. 2006. Phospholipid hydroxyalkenals, a subset of recently discovered endogenous CD36 ligands, spontaneously generate novel furan-containing phospholipids lacking CD36 binding activity in vivo. J. Biol. Chem. 281: 31298-31308.
40. Balamraju, Y. N., M. Sun, and R. G. Salomon. 2004. Gamma-hydroxyalkenals are oxidatively cleaved through Michael addition of acylperoxy radicals and fragmentation of intermediate beta- hydroxyperesters. J. Am. Chem. Soc. 126: 11522-11528.
41. Simons, K., and E. Ikonen. 1997. Functional rafts in cell membranes. Nature. 387: 569-572.
42. Calder, P. C., and P. Yaqoob. 2007. Lipid rafts-composition, characterization, and controversies. J. Nutr. 137: 545-547.
43. Evans, T. A., S. L. Siedlak, L. Lu, X. Fu, Z. Wang, W. R. McGinnis, E. Fakhoury, R. J. Castellani, S. L. Hazen, W. J. Walsh, et al. 2008. The autistic phenotype exhibits a remarkably localized modification of brain protein by products of free radical-induced lipid oxidation. Am. J. Biotech. Biochem. 4: 61-72.
44. Schmidt, R., U. Meier, P. Markart, F. Grimminger, H. G. Velcovsky, H. Morr, W. Seeger, and A. Gunther. 2002. Altered fatty acid composition of lung surfactant phospholipids in interstitial lung disease. Am. J. Physiol. 283: L1079-L1085.